VERICIGUAT

/static/temp/default.svg Search structure
Synonyms
Status
Molecule Category UNKNOWN
ATC C01DX22
UNII LV66ADM269

Structure

InChI Key QZFHIXARHDBPBY-UHFFFAOYSA-N
Smiles COC(=O)Nc1c(N)nc(-c2nn(Cc3ccccc3F)c3ncc(F)cc23)nc1N
InChI
InChI=1S/C19H16F2N8O2/c1-31-19(30)25-14-15(22)26-17(27-16(14)23)13-11-6-10(20)7-24-18(11)29(28-13)8-9-4-2-3-5-12(9)21/h2-7H,8H2,1H3,(H,25,30)(H4,22,23,26,27)

Physicochemical Descriptors

Property Name Value
Molecular Formula C19H16F2N8O2
Molecular Weight 426.39
AlogP 2.56
Hydrogen Bond Acceptor 9.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 4.0
Polar Surface Area 146.86
Molecular species NEUTRAL
Aromatic Rings 4.0
Heavy Atoms 31.0

Bioactivity

Mechanism of Action Action Reference
Soluble guanylate cyclase activator ACTIVATOR FDA PubMed
Protein: Soluble guanylate cyclase
Description: Guanylate cyclase soluble subunit alpha-2
Organism : Homo sapiens
P33402 ENSG00000152402
Protein: Soluble guanylate cyclase
Description: Guanylate cyclase soluble subunit alpha-1
Organism : Homo sapiens
Q02108 ENSG00000164116
Protein: Soluble guanylate cyclase
Description: Guanylate cyclase soluble subunit beta-1
Organism : Homo sapiens
Q02153 ENSG00000061918
Assay Description Organism Bioactivity Reference
Stimulation of rat sGC expressed in CHO cells using GTP as substrate assessed as increase in cGMP formation treated for 6 mins in presence of 30 nM SNAP by luminescence assay Rattus norvegicus 39.0 nM
Stimulation of rat sGC expressed in CHO cells using GTP as substrate assessed as increase in cGMP formation treated for 6 mins in presence of 100 nM SNAP by luminescence assay Rattus norvegicus 10.6 nM
Stimulation of rat sGC expressed in CHO cells using GTP as substrate assessed as increase in cGMP formation treated for 6 mins in presence of sGC inhibitor ODQ by luminescence assay Rattus norvegicus 256.0 nM
Inhibition of phenylephrine-induced contractions in Chinchilla rabbit saphenous artery rings administered at the beginning of the last resting period of 28 mins Oryctolagus cuniculus 798.0 nM
Inhibition of phenylephrine-induced contractions in Chinchilla rabbit aortic rings administered at the beginning of the last resting period of 28 mins Oryctolagus cuniculus 692.0 nM
Vasorelaxant activity in normal Chinchilla rabbit saphenous artery ring administered at the beginning of the last resting period of 28 mins Oryctolagus cuniculus 5.6 nM
Vasorelaxant activity in nirate-tolerant Chinchilla rabbit saphenous artery ring administered at the beginning of the last resting period of 28 mins in presence of sorbide dinitrate Oryctolagus cuniculus 5.8 nM
Inhibition of U46619-induced contractions in porcine coronary artery rings Sus scrofa 956.0 nM

Related Entries

Cross References

Resources Reference
ChEBI 142432
ChEMBL CHEMBL4066936
DrugBank DB15456
FDA SRS LV66ADM269
Guide to Pharmacology 10010
PubChem 54674461
SureChEMBL SCHEMBL429958
ZINC ZINC000072318626
CONTENTS